QBBHY yields 2.59% · JNJ yields 2.13%● Live data
📍 QBBHY pulled ahead of the other in Year 1
Combined, QBBHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QBBHY + JNJ for your $10,000?
Qube Holdings Limited, together with its subsidiaries, provides logistics solutions for import and export supply chain in Australia, New Zealand, and internationally. The company's Operating division offers services relating to the import and export of primarily containerized cargo; provides various logistics services, which includes road and rail transport, warehousing and distribution, container parks, and related services, as well as operates intermodal logistics hubs, including rail terminals and international freight forwarding; owns and operates automotive terminals that provides automotive, general cargo, and break-bulk facilities; operates multi-user grain storage and handling facilities; and develops and operates an import-export rail terminal, and an interstate rail terminal at the Moorebank Logistics Park. This division also provides bulk and general handling facilities; and bulk material handling services, including road and rail transport, stockpile management, and bulk ship loading services. Its Patrick Terminals division provides container stevedoring services in Australia. The company was formerly known as Qube Logistics Holdings Limited and changed its name to Qube Holdings Limited in November 2012. Qube Holdings Limited was incorporated in 2011 and is based in Sydney, Australia.
Full QBBHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.